Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats

Zhao,Jinyan; Hu,Haixia; Wan,Yun; Zhang,Yuchen; Zheng,Liangpu; Hong,Zhenfeng

doi:10.3892/etm.2017.4174

Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats

Authors:
- Jinyan Zhao
- Haixia Hu
- Yun Wan
- Yuchen Zhang
- Liangpu Zheng
- Zhenfeng Hong
View Affiliations

Affiliations: Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China
Published online on: March 2, 2017 https://doi.org/10.3892/etm.2017.4174
Pages: 1820-1826
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver damage results from a variety of insults, including hepatitis and chemical toxicity from alcohol, drugs and other toxins. The present study evaluated the hepatoprotective effects and potential mechanisms of action of the Traditional Chinese Medicine Pien Tze Huang Gan Bao (GB) in a rat model of carbon tetrachloride (CCl4)‑induced liver injury. Sixty male Sprague‑Dawley rats were randomly divided into six different groups: i) Control, ii) CCl4 injury model and groups treated with iii) silymarin as a positive drug control, iv) 150 mg/kg GB, v) 300 mg/kg GB and vi) 600 mg/kg GB. Control rats received no treatment, while the remaining ones were intraperitoneally injected with CCl4 (2 ml/kg) to induce acute liver disease. Silymarin or GB was orally administered prior to CCl4 treatment in various treatment groups for 7 days. Animals were sacrificed 24 h post‑CCl4 injection. It was revealed that GB significantly reduced serum aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma glutamyl transpeptidase and total bilirubin levels in the serum induced by CCl4. BG also prevented CCl4‑induced changes in liver tissues, as revealed by histopathological analysis. CCl4‑induced reductions in endogenous liver antioxidant enzyme activities of superoxide dismutase, glutathione and glutathione peroxidase as well as increases in malondialdehyde and thiobarbituric acid reactive substances were inhibited by GB treatment. Activated NF‑κB in liver tissues was also significantly increased by CCl4, which was attenuated by GB as indicated by immunohistochemical and PCR analysis. Furthermore, CCl4‑mediated increases in the inflammatory factors tumor necrosis factor‑alpha and interleukin‑1β secretion into the serum and their expression in liver tissues were reversed following GB treatment, as revealed by ELISA and PCR, respectively. These findings suggested that GB protects against CCl4‑induced hepatic injury, inflammation and oxidative damage in rats and may be useful in future clinical application of liver injury and disease.

View Figures

View References

1	Güven A, Güven A and Gülmez M: The effect of kefir on the activities of GSH-Px, GST, CAT, GSH and LPO levels in carbon tetrachloride-induced mice tissues. J Vet Med B Infect Dis Vet Public Health. 50:412–416. 2003. View Article : Google Scholar : PubMed/NCBI
2	Ogeturk M, Kus I, Colakoglu N, Zararsiz I, Ilhan N and Sarsilmaz M: Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol. 97:273–280. 2005. View Article : Google Scholar : PubMed/NCBI
3	Jaramillo-Juárez F, Rodríguez-Vázquez ML, Rincón-Sánchez AR, Consolación Martínez M, Ortiz GG, Llamas J, Anibal Posadas F and Reyes JL: Acute renal failure induced by carbon tetrachloride in rats with hepatic cirrhosis. Ann Hepatol. 7:331–338. 2008.PubMed/NCBI
4	Galligani L, Lonati-Galligani M and Fuller GC: Collagen synthesis in explant cultures of normal and CCl4-treated mouse liver. Toxicol Appl Pharmacol. 48:131–137. 1979. View Article : Google Scholar : PubMed/NCBI
5	Recknagel RO, Glende EA Jr, Dolak JA and Waller RL: Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther. 43:139–154. 1989. View Article : Google Scholar : PubMed/NCBI
6	Slater TF: Free-radical mechanisms in tissue injury. Biochem J. 222:1–15. 1984. View Article : Google Scholar : PubMed/NCBI
7	Poli G: Liver damage due to free radicals. Br Med Bull. 49:604–620. 1993. View Article : Google Scholar : PubMed/NCBI
8	Johnson SJ, Hines JE and Burt AD: Macrophage and perisinusoidal cell kinetics in acute liver injury. J Pathol. 166:351–358. 1992. View Article : Google Scholar : PubMed/NCBI
9	Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, Kawauchi Y, Kawachi H, Shimizu F, Matsushima K, et al: Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol. 32:3197–3205. 2002. View Article : Google Scholar : PubMed/NCBI
10	Kalinichenko VV, Bhattacharyya D, Zhou Y, Gusarova GA, Kim W, Shin B and Costa RH: Foxf1 +/− mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl₄ injury. Hepatology. 37:107–117. 2003. View Article : Google Scholar : PubMed/NCBI
11	Steinman L, Martin R, Bernard C, Conlon P and Oksenberg JR: Multiple sclerosis: Deeper understanding of its pathogenesis reveals new targets for therapy. Annu Rev Neurosci. 25:491–505. 2002. View Article : Google Scholar : PubMed/NCBI
12	Morio LA, Chiu H, Sprowles KA, Zhou P, Heck DE, Gordon MK and Laskin DL: Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol. 172:44–51. 2001. View Article : Google Scholar : PubMed/NCBI
13	Weber LW, Boll M and Stampfl A: Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 33:105–136. 2003. View Article : Google Scholar : PubMed/NCBI
14	Miyazaki T, Bouscarel B, Ikegami T, Honda A and Matsuzaki Y: The protective effect of taurine against hepatic damage in a model of liver disease and hepatic stellate cells. Adv Exp Med Biol. 643:293–303. 2009. View Article : Google Scholar : PubMed/NCBI
15	Kolios G, Valatas V and Kouroumalis E: Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol. 12:7413–7420. 2006. View Article : Google Scholar : PubMed/NCBI
16	Luckey SW and Petersen DR: Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp Mol Pathol. 71:226–240. 2001. View Article : Google Scholar : PubMed/NCBI
17	Yang L, Magness ST, Bataller R, Rippe RA and Brenner DA: NF-kappaB activation in Kupffer cells after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 289:G530–G538. 2005. View Article : Google Scholar : PubMed/NCBI
18	Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358. 1979. View Article : Google Scholar : PubMed/NCBI
19	McCord JM and Fridovich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 244:6049–6055. 1969.PubMed/NCBI
20	Beutler E, Duron O and Kelly BM: Improved method for the determination of blood glutathione. J Lab Clin Med. 61:882–888. 1963.PubMed/NCBI
21	Suja SR, Latha PG, Pushpangadan P and Rajasekharan S: Evaluation of hepatoprotective effects of Helminthostachys zeylanica (L.) Hook against carbon tetrachloride-induced liver damage in Wistar rats. J Ethnopharmacol. 92:61–66. 2004. View Article : Google Scholar : PubMed/NCBI
22	Kwak JH, Kim HJ, Lee KH, Kang SC and Zee OP: Antioxidative iridoid glycosides and phenolic compounds from Veronica peregrina. Arch Pharm Res. 32:207–213. 2009. View Article : Google Scholar : PubMed/NCBI
23	Abe Y, Hashimoto S and Horie T: Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res. 39:41–47. 1999. View Article : Google Scholar : PubMed/NCBI
24	Drotman RB and Lawhorn GT: Serum enzymes as indicators of chemically induced liver damage. Drug Chem Toxicol. 1:163–171. 1978. View Article : Google Scholar : PubMed/NCBI
25	Wolf PL: Biochemical diagnosis of liver disease. Indian J Clin Biochem. 14:59–90. 1999. View Article : Google Scholar : PubMed/NCBI
26	Cemek M, Aymelek F, Büyükokuroğlu ME, Karaca T, Büyükben A and Yilmaz F: Protective potential of Royal Jelly against carbon tetrachloride induced-toxicity and changes in the serum sialic acid levels. Food Chem Toxicol. 48:2827–2832. 2010. View Article : Google Scholar : PubMed/NCBI
27	Cheeseman KH: Mechanisms and effects of lipid peroxidation. Mol Aspects Med. 14:191–197. 1993. View Article : Google Scholar : PubMed/NCBI
28	Pompella A, Visvikis A, Paolicchi A, De Tata V and Casini AF: The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 66:1499–1503. 2003. View Article : Google Scholar : PubMed/NCBI
29	Maritim AC, Sanders RA and Watkins JB III: Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem. 14:288–294. 2003. View Article : Google Scholar : PubMed/NCBI
30	Ramadori G and Armbrust T: Cytokines in the liver. Eur J Gastroenterol Hepatol. 13:777–784. 2001. View Article : Google Scholar : PubMed/NCBI
31	Simpson KJ, Lukacs NW, Colletti L, Strieter RM and Kunkel SL: Cytokines and the liver. J Hepatol. 27:1120–1132. 1997. View Article : Google Scholar : PubMed/NCBI
32	Neuman MG: Cytokines-central factors in alcoholic liver disease. Alcohol Res Health. 27:307–316. 2003.PubMed/NCBI
33	Oakley F, Mann J, Nailard S, Smart DE, Mungalsingh N, Constandinou C, Ali S, Wilson SJ, Millward-Sadler H, Iredale JP and Mann DA: Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol. 166:695–708. 2005. View Article : Google Scholar : PubMed/NCBI